Published 2 days ago • loading... • Updated 2 days ago

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference. Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth

1 Articles

MarketBeat

Center

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

2 days ago·Sioux Falls, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated2 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States 2 days ago on Tuesday, September 15, 2026.

Sources are mostly out of (0)

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

1 Articles

1 Articles

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

House to leave early, punting Hegseth impeachment vote until after November elections

Trump promised to publicly shame the Smithsonian this summer. So the administration is now installing signs to do it: 'Anti-white animus'

Georgia death row inmate gets last-minute stay, for now, while an execution in Texas is on track

France Recorded at Least 817 Excess Deaths During July 27-August 20 Heatwaves

Ukraine proposes record defence spending next year as war costs soar

CMHC reports annual pace of housing starts edged lower in August

Similar News Topics

Similar News Topics

More stories like this

House to leave early, punting Hegseth impeachment vote until after November elections

Trump promised to publicly shame the Smithsonian this summer. So the administration is now installing signs to do it: 'Anti-white animus'

Georgia death row inmate gets last-minute stay, for now, while an execution in Texas is on track

France Recorded at Least 817 Excess Deaths During July 27-August 20 Heatwaves

Ukraine proposes record defence spending next year as war costs soar

CMHC reports annual pace of housing starts edged lower in August

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

1 Articles

1 Articles

Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

House to leave early, punting Hegseth impeachment vote until after November elections

Trump promised to publicly shame the Smithsonian this summer. So the administration is now installing signs to do it: 'Anti-white animus'

Georgia death row inmate gets last-minute stay, for now, while an execution in Texas is on track

France Recorded at Least 817 Excess Deaths During July 27-August 20 Heatwaves

Ukraine proposes record defence spending next year as war costs soar

CMHC reports annual pace of housing starts edged lower in August

Similar News Topics

Similar News Topics

More stories like this

House to leave early, punting Hegseth impeachment vote until after November elections

Trump promised to publicly shame the Smithsonian this summer. So the administration is now installing signs to do it: 'Anti-white animus'

Georgia death row inmate gets last-minute stay, for now, while an execution in Texas is on track

France Recorded at Least 817 Excess Deaths During July 27-August 20 Heatwaves

Ukraine proposes record defence spending next year as war costs soar

CMHC reports annual pace of housing starts edged lower in August

Bias Distribution

Factuality